The Business Times
business-time-50

drugmaker

International

Sanofi profit rises on blockbuster drug in lift for incoming CEO

CVC last month offered to take over Recordati for 52 euro a share, after previously exploring a sale of its stake in the Italian company.
Consumer & Healthcare

CVC seeks partners to back 10.9 billion-euro Italian drugmaker Recordati deal: sources

Bayer's lacklustre earnings forecast comes as its CEO struggled to revive a stock battered by costly litigation and massive financial debt.
Companies & Markets

Bayer’s profit guidance falls short of expectations

The FDA PreCheck programme, first announced in August, aims to streamline review of domestic pharmaceutical plants and eliminate unnecessary regulatory requirements.
International

US FDA launches programme to boost domestic drug manufacturing

To promote growth, Hisamitsu is stepping up overseas expansion as it faces intensifying competition at home.
Consumer & Healthcare

CEO of Salonpas maker seeks to take the 450 billion yen drug firm private

The tool is expected to streamline clinical trials for Mash, a condition that affects millions of Americans and can lead to liver failure or cancer, the FDA says.
Lifestyle

US FDA qualifies first AI tool to help speed liver disease drug development

The tussle for Metsera began with discussions between the company and potential acquirers in early 2024, with both Pfizer and Novo Nordisk, the maker of Wegovy and Ozempic, expressing interest.
Companies & Markets

Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid

Pfizer’s top-selling drugs include the blood-thinner Eliquis, the pneumonia vaccine Prevnar, and a shot and pill for Covid-19.
Consumer & Healthcare

Pfizer’s drug price cuts yield three-year Trump tariff reprieve

Moderna shares dropped 7.4% in New York Friday. Pfizer shares fell 4%, while BioNTech’s US-traded shares sank 7.3%.
Consumer & Healthcare

Drugmakers fall on report US to claim Covid shot killed kids

Merck plans to reduce its global real estate footprint and optimise its manufacturing network.
Consumer & Healthcare

Merck to cut jobs and costs as demand for Gardasil in China remains weak

Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More